Medical science Medicine Networking 
Copyright Clearance Center
AUGUST 9, 2022
At the JAMA Network, we are interested in providing our readers the most seamless access to the research, opinion, and clinical educational content we publish,” said Vida Damijonaitis, JAMA Network Director of Worldwide Sales.
European Pharmaceutical Review
NOVEMBER 21, 2024
In his over 11-year tenure at Pfizer thus far, Dr Boshoff he has delivered 24 approved innovative medicines and biosimilars in over 30 indications, according to Pfizer. “Dr He trained as medical oncologist at the Royal Marsden and Royal Free Hospitals in London. Academy of Medical Sciences. “I
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
OCTOBER 31, 2024
It pledges to benefit key industry sectors across life sciences including R&D, innovation, manufacturing and medicine. Autumn Budget – looking ahead However, it is important to be realistic, urged Sharon Todd, CEO of UK-based Innovation Network SCI. “R&D
PM360
NOVEMBER 21, 2022
Combined with the incentives provided by the Orphan Drug Act, a powerful dynamic is at play, ever further pushing the limits of what medical science can achieve. Accelerating the Path to Diagnosis and Treatment. However, this bustling space also faces some unique challenges. Understanding Rare Disease Communities.
Clarivate
JUNE 21, 2022
Each year, the Journal Citation Reports (JCR) release provides a summary of the network of scholarly citations from the prior year of Web of Science coverage. The massive and rapid response of the scholarly community to COVID-19 extends far beyond medical care or medical sciences, and its ripples will continue for years, or decades.
Pharmaceutical Technology
NOVEMBER 2, 2022
The pharmaceutical community has reached somewhat of a turning point as it commercialises a growing number of speciality medicines relying on complex new treatment pathways. As with many aspects of the medical world, they are now shifting online. With this comes new hope for previously underserved patient populations.
Celeritas
OCTOBER 14, 2022
Medical Science Liaisons are hired or contracted to meet with these stakeholders prior to and during the launch and distribution period to educate and create awareness of the drug. Secondary: These are those who will ultimately determine the lifecycle and success of advanced treatments, diagnostic tools, and medications.
Expert insights. Personalized for you.
116 
Let's personalize your content